Lang AE - Search Results

1

GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.

Barker RA, Björklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells AP, Fiandaca MS, Stoessl AJ, Eidelberg D, Federoff H, Voutilainen MH, Dexter DT, Eberling J, Brundin P, Isaacs L, Mursaleen L, Bresolin E, Carroll C, Coles A, Fiske B, Matthews H, Lungu C, Wyse RK, Stott S, Lang AE. Barker RA, et al. Among authors: lang ae. J Parkinsons Dis. 2020;10(3):875-891. doi: 10.3233/JPD-202004. J Parkinsons Dis. 2020. PMID: 32508331 Free PMC article. Review.

2

What is it? Case 1, 1990: progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb.

Greene PE, Fahn S, Lang AE, Watts RL, Eidelberg D, Powers JM. Greene PE, et al. Among authors: lang ae. Mov Disord. 1990;5(4):341-51. doi: 10.1002/mds.870050420. Mov Disord. 1990. PMID: 2259362 No abstract available.

3

Treatment of early Parkinson's disease.

Grimes DA, Lang AE. Grimes DA, et al. Among authors: lang ae. Can J Neurol Sci. 1999 Aug;26 Suppl 2:S39-44. doi: 10.1017/s0317167100000081. Can J Neurol Sci. 1999. PMID: 10451759 Review.

4

Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.

Fukuda M, Mentis MJ, Ma Y, Dhawan V, Antonini A, Lang AE, Lozano AM, Hammerstad J, Lyons K, Koller WC, Moeller JR, Eidelberg D. Fukuda M, et al. Among authors: lang ae. Brain. 2001 Aug;124(Pt 8):1601-9. doi: 10.1093/brain/124.8.1601. Brain. 2001. PMID: 11459751

5

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ; REAL-PET Study Group. Whone AL, et al. Among authors: lang ae. Ann Neurol. 2003 Jul;54(1):93-101. doi: 10.1002/ana.10609. Ann Neurol. 2003. PMID: 12838524 Clinical Trial.

6

Analysis of the glucocerebrosidase gene in Parkinson's disease.

Sato C, Morgan A, Lang AE, Salehi-Rad S, Kawarai T, Meng Y, Ray PN, Farrer LA, St George-Hyslop P, Rogaeva E. Sato C, et al. Among authors: lang ae. Mov Disord. 2005 Mar;20(3):367-70. doi: 10.1002/mds.20319. Mov Disord. 2005. PMID: 15517592

7

Progress in clinical neurosciences: a forum on the early management of Parkinson's disease.

Lang AE, Miyasaki J, Olanow CW, Stoessl AJ, Suchowersky O. Lang AE, et al. Can J Neurol Sci. 2005 Aug;32(3):277-86. doi: 10.1017/s0317167100004145. Can J Neurol Sci. 2005. PMID: 16225167 Review.

8

Crossroads in GDNF therapy for Parkinson's disease.

Sherer TB, Fiske BK, Svendsen CN, Lang AE, Langston JW. Sherer TB, et al. Among authors: lang ae. Mov Disord. 2006 Feb;21(2):136-41. doi: 10.1002/mds.20861. Mov Disord. 2006. PMID: 16470786

9

Is there seasonal variation in risk of Parkinson's disease?

Postuma RB, Wolfson C, Rajput A, Stoessl AJ, Martin WR, Suchowersky O, Chouinard S, Panisset M, Jog MS, Grimes DA, Marras C, Lang AE. Postuma RB, et al. Among authors: lang ae. Mov Disord. 2007 Jun 15;22(8):1097-101. doi: 10.1002/mds.21272. Mov Disord. 2007. PMID: 17486603

10

Dopaminergic transplantation for Parkinson's disease: current status and future prospects.

Olanow CW, Kordower JH, Lang AE, Obeso JA. Olanow CW, et al. Among authors: lang ae. Ann Neurol. 2009 Nov;66(5):591-6. doi: 10.1002/ana.21778. Ann Neurol. 2009. PMID: 19938101 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,132 results

Search Page